Cargando…

Oral Dyskinesia in a Pediatric Patient Following Concurrent Use of Neuroleptics and Stimulants: Treatment Strategy Considerations to Avert Avoidable Adverse Side Effects

Withdrawal-emergent dyskinesia is a movement disorder that emerges following sudden discontinuation or rapid taper of antipsychotic medication. It is infrequently identified and typically resolves within a few weeks from symptom onset. This case report describes a unique case of reversible oral dysk...

Descripción completa

Detalles Bibliográficos
Autores principales: Haji Rahman, Rangin, Dharmapuri, Sanjaya
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10226429/
https://www.ncbi.nlm.nih.gov/pubmed/37255893
http://dx.doi.org/10.7759/cureus.38294
_version_ 1785050572761595904
author Haji Rahman, Rangin
Dharmapuri, Sanjaya
author_facet Haji Rahman, Rangin
Dharmapuri, Sanjaya
author_sort Haji Rahman, Rangin
collection PubMed
description Withdrawal-emergent dyskinesia is a movement disorder that emerges following sudden discontinuation or rapid taper of antipsychotic medication. It is infrequently identified and typically resolves within a few weeks from symptom onset. This case report describes a unique case of reversible oral dyskinesia in a 13-year-old male in the context of concurrent neuroleptic withdrawal and stimulant titration. The extant literature describing tardive dyskinesia is well-established; however, few studies have thoroughly examined withdrawal-emergent dyskinesia and other tardive syndromes. This report highlights the importance of clinician awareness as far as the potential for extrapyramidal symptoms and withdrawal-emergent adverse effects in concomitant management of antipsychotics and stimulants in the child and adolescent populations and may help inform future treatment and management of disorders that would indicate the concurrent use of these psychotropics.
format Online
Article
Text
id pubmed-10226429
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Cureus
record_format MEDLINE/PubMed
spelling pubmed-102264292023-05-30 Oral Dyskinesia in a Pediatric Patient Following Concurrent Use of Neuroleptics and Stimulants: Treatment Strategy Considerations to Avert Avoidable Adverse Side Effects Haji Rahman, Rangin Dharmapuri, Sanjaya Cureus Pediatrics Withdrawal-emergent dyskinesia is a movement disorder that emerges following sudden discontinuation or rapid taper of antipsychotic medication. It is infrequently identified and typically resolves within a few weeks from symptom onset. This case report describes a unique case of reversible oral dyskinesia in a 13-year-old male in the context of concurrent neuroleptic withdrawal and stimulant titration. The extant literature describing tardive dyskinesia is well-established; however, few studies have thoroughly examined withdrawal-emergent dyskinesia and other tardive syndromes. This report highlights the importance of clinician awareness as far as the potential for extrapyramidal symptoms and withdrawal-emergent adverse effects in concomitant management of antipsychotics and stimulants in the child and adolescent populations and may help inform future treatment and management of disorders that would indicate the concurrent use of these psychotropics. Cureus 2023-04-29 /pmc/articles/PMC10226429/ /pubmed/37255893 http://dx.doi.org/10.7759/cureus.38294 Text en Copyright © 2023, Haji Rahman et al. https://creativecommons.org/licenses/by/3.0/This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Pediatrics
Haji Rahman, Rangin
Dharmapuri, Sanjaya
Oral Dyskinesia in a Pediatric Patient Following Concurrent Use of Neuroleptics and Stimulants: Treatment Strategy Considerations to Avert Avoidable Adverse Side Effects
title Oral Dyskinesia in a Pediatric Patient Following Concurrent Use of Neuroleptics and Stimulants: Treatment Strategy Considerations to Avert Avoidable Adverse Side Effects
title_full Oral Dyskinesia in a Pediatric Patient Following Concurrent Use of Neuroleptics and Stimulants: Treatment Strategy Considerations to Avert Avoidable Adverse Side Effects
title_fullStr Oral Dyskinesia in a Pediatric Patient Following Concurrent Use of Neuroleptics and Stimulants: Treatment Strategy Considerations to Avert Avoidable Adverse Side Effects
title_full_unstemmed Oral Dyskinesia in a Pediatric Patient Following Concurrent Use of Neuroleptics and Stimulants: Treatment Strategy Considerations to Avert Avoidable Adverse Side Effects
title_short Oral Dyskinesia in a Pediatric Patient Following Concurrent Use of Neuroleptics and Stimulants: Treatment Strategy Considerations to Avert Avoidable Adverse Side Effects
title_sort oral dyskinesia in a pediatric patient following concurrent use of neuroleptics and stimulants: treatment strategy considerations to avert avoidable adverse side effects
topic Pediatrics
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10226429/
https://www.ncbi.nlm.nih.gov/pubmed/37255893
http://dx.doi.org/10.7759/cureus.38294
work_keys_str_mv AT hajirahmanrangin oraldyskinesiainapediatricpatientfollowingconcurrentuseofneurolepticsandstimulantstreatmentstrategyconsiderationstoavertavoidableadversesideeffects
AT dharmapurisanjaya oraldyskinesiainapediatricpatientfollowingconcurrentuseofneurolepticsandstimulantstreatmentstrategyconsiderationstoavertavoidableadversesideeffects